These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sensitivity of personalized circulating tumor DNA assay in advanced cutaneous squamous cell carcinoma. Kim EY; Ruiz ES; Hanna GJ; Thakuria M; Silk AW J Am Acad Dermatol; 2024 Feb; 90(2):427-429. PubMed ID: 37844691 [No Abstract] [Full Text] [Related]
3. The application of circulating tumor DNA in advanced cutaneous squamous cell carcinoma: Potential opportunities and challenges. Sun H; Shen W; Zhong HJ J Am Acad Dermatol; 2024 Aug; 91(2):e31-e32. PubMed ID: 38593973 [No Abstract] [Full Text] [Related]
4. Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy. Jacob JM; Ferry EK; Gay LM; Elvin JA; Vergilio JA; Ramkissoon S; Severson E; Necchi A; Killian JK; Ali SM; Schrock AB; Liu NW; Chung J; Miller VA; Stephens PJ; Welsh A; Corona RJ; Ross JS; Bratslavsky G J Urol; 2019 Mar; 201(3):541-548. PubMed ID: 30291913 [TBL] [Abstract][Full Text] [Related]
5. The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma. Harwood CA; Proby CM; Inman GJ; Leigh IM Acta Derm Venereol; 2016 Jan; 96(1):3-16. PubMed ID: 26084328 [TBL] [Abstract][Full Text] [Related]
6. Diversity of circulating tumor cells in peripheral blood: Detection of heterogeneous BRAF mutations in a patient with advanced melanoma by single-cell analysis. Kiniwa Y; Nakamura K; Mikoshiba A; Akiyama Y; Morimoto A; Okuyama R J Dermatol Sci; 2018 May; 90(2):211-213. PubMed ID: 29426605 [No Abstract] [Full Text] [Related]
7. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217 [TBL] [Abstract][Full Text] [Related]
8. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia. Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856 [TBL] [Abstract][Full Text] [Related]
9. Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets. Ashford BG; Clark J; Gupta R; Iyer NG; Yu B; Ranson M Head Neck; 2017 Jul; 39(7):1462-1469. PubMed ID: 28370784 [TBL] [Abstract][Full Text] [Related]